A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With
Recurrent or Progressive Glioblastoma Following Initial Therapy
Does the drug DSP-7888 help patients with glioblastoma?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
This is a randomized, active-controlled, multicenter, open-label, parallel groups,
study of DSP-7888 Dosing Emulsion plus Bevacizumab versus Bevacizumab alone in patients
recurrent or progressive glioblastoma multiforme (GBM) following treatment with first
therapy consisting of surgery and radiation with or without chemotherapy.
Study Contact InformationStudy Coordinator: Boston Biomedical
Phone: (844) 904-7088
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search